TVM Capital

About The Fund

TVM Capital is an international venture capital firm that specializes in investments in the life sciences sector, including biotech, pharmaceutical, and medtech companies. Operating with offices based in Munich, Germany and Montreal, Canada, they have a transatlantic approach that enables them to tap into markets in both Europe and North America. Their investment strategy revolves around financing innovative companies that have the potential to significantly improve therapeutic approaches and health outcomes. They primarily target early to mid-stage investment opportunities where they can add value through their extensive network of industry professionals, entrepreneurs, and scientists. With a track record of successful exits and a strategy firmly grounded in scientific expertise and market knowledge, TVM Capital aims to deliver attractive returns to their investors. The fund seeks to partner with visionary entrepreneurs to develop products and services that can meet unmet medical needs, signifying their commitment to not only financial success but also to the betterment of healthcare on a global scale. They emphasize active collaboration with portfolio companies, providing operational support and strategic guidance to foster growth and innovation. One of the key aspects of their investment thesis is the identification and support of groundbreaking scientific research that has strong commercialization potential. TVM Capital prides itself on being a value-adding investor with a long-term vision for the successes of their portfolio companies and, ultimately, positive impacts on healthcare systems.